IKENA ONCOLOGY INC's ticker is IKNA and the CUSIP is 45175G108. A total of 40 filers reported holding IKENA ONCOLOGY INC in Q1 2023. The put-call ratio across all filers is - and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $2,315,065 | -31.8% | 534,657 | +3.3% | 0.01% | -26.3% |
| Q2 2023 | $3,395,213 | +86.0% | 517,563 | -2.2% | 0.02% | +58.3% |
| Q1 2023 | $1,825,050 | +29.7% | 529,000 | 0.0% | 0.01% | +71.4% |
| Q4 2022 | $1,407,140 | -25.1% | 529,000 | 0.0% | 0.01% | -36.4% |
| Q3 2022 | $1,878,000 | -19.8% | 529,000 | 0.0% | 0.01% | -69.4% |
| Q2 2022 | $2,343,000 | – | 529,000 | – | 0.04% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Atlas Venture Life Science Advisors, LLC | 5,018,178 | $30,611,000 | 3.87% |
| Omega Fund Management, LLC | 2,249,123 | $13,720,000 | 2.81% |
| CHI Advisors LLC | 814,755 | $4,970,000 | 2.11% |
| BVF INC/IL | 2,501,571 | $15,260,000 | 0.61% |
| Artal Group S.A. | 1,549,513 | $9,452,000 | 0.40% |
| Orbimed Advisors | 2,933,941 | $17,897,000 | 0.29% |
| Logos Global Management LP | 178,281 | $1,088,000 | 0.14% |
| HealthCor Management, L.P. | 287,621 | $1,754,000 | 0.12% |
| FARALLON CAPITAL MANAGEMENT LLC | 792,077 | $4,832,000 | 0.02% |
| Point72 Asset Management, L.P. | 348,696 | $2,127,000 | 0.01% |